diagnosed using tool treated with has mode of inheritance has causal genotype has causal or contributing genetic variation has manifestation has causal molecular phenotype in guideline Acute Chest Syndrome Splenomegaly Reduced Beta/Alpha Synthesis Ratio Genetic Testing Ibuprofen Blood Smear Sickle Beta Thalassemia Acetaminophen Hemoglobin S Hemoglobin Profile Assay Reduced Hemoglobin A Sickle Cell Disease-S Beta Minus Thalassemia A mild form of sickle cell thalassemia characterized by the presence of hemoglobin S and a reduced amount of hemoglobin A in the red blood cells. It is characterized by the presence of small red blood cells and mild anemia. NCIT:C98837 Suggest update to label Sickle B- Thalassemia Suggest update to label in NCIT from "Sickle Beta Plus Thalassemia" to "Sickle Beta Minus Thalassemia" Sickle Cell Disease-S Beta Minus Thalassemia Sickle Cell-B- Thalassemia S beta-minus Sickle Cell-Beta Minus Thalassemia http://bioportal.bioontology.org/ontologies/NCIT/?p=classes&conceptid=http%3A%2F%2Fncicb.nci.nih.gov%2Fxml%2Fowl%2FEVS%2FThesaurus.owl%23C98837 Sickle Beta Minus Thalassemia Stroke Beta-Minus Thalassemia Mutation Splenic Infarction Hypersplenism Splenic Sequestration HBB, GLU6VAL Recommendations for the Management of Sickle Cell Disease in South Africa National Guideline for the Control and Management of Sickle Cell Disease A Parental Guide to Managing Sickle Cell Disease Standards for Clinical Care of Adults with Sickle Cell Disease in the UK Sickle Cell Disease: The Clinical Care Guidelines of the Sickle Cell Unit Consensus Statement on the Care of Patients with Sickle Cell Disease in Canada Sickle Cell Disease in Children, Standards and Guidelines for Clinic Care Evidence-Based Management of Sickle Cell Disease Management of Children with Sickle Cell Disease in Europe: Current Situation and Future Perspectives Hemoglobin Genotype S/Beta Minus Thalassaemia Autosomal Recessive Compound Heterozygous